Effect of Tecar in Addition of Functional Massage in Post-stroke Spasticity (Tecar)
Stroke Sequelae, Massage, Spasticity, Muscle
About this trial
This is an interventional treatment trial for Stroke Sequelae focused on measuring Stroke, Spasticity, Tecar therapy, Functional massage, Muscle tone, Capacitive Resistive Electric Transfer Therapy (CRet)
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Stroke
- Scoring 1 on the Modified Ashworth Scale (MAS) for hip or/and knee flexion or/and ankle dorsiflexion on the most affected limb
- Scoring 25 or plus on the Montreal Cognitive Assessment (MoCA)
Exclusion Criteria:
- Having suffered a traumatism on the lower limbs three months, or less, before the intervention
- Suffer other neurological disease
- Presence of osteosynthetic material
- Pacemaker wearing
- Treatment with botulinum toxin or another antispastic medication, six months , or less, before the intervention
- Carry baclofen pump
- Functional inability to adopt the prone or supine position on the treatment table
- Functional inability to sit, stand and walk
- Poor language and communication skills that make difficult to understand the informed consent
- Contraindications to Functional Massage (infectious diseases, inflammatory vascular conditions, acute inflammation, hemorrhagic, fever)
Sites / Locations
- Universitat Internacional de Catalunya
- Laura Garcia Rueda
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Experimental group
Control group
30 min session of Tecar Therapy with functional massage on the rectus femoris, and gastrocnemius. Tecar therapy in the resistive modality (80W) on lower back and hamstrings and in rectus femoris and gastrocnemius with resistive mode (100-120W), and then in capacitive mode(180-200VA)
30 min session of Tecar Therapy with functional massage on the rectus femoris, and gastrocnemius. Sham stimulation was provided by only turn on the device but dose is 0.